Inventor
ANNETTE ATKINS
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C12NMicroorganisms or enzymes14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
C07BGeneral methods of organic chemistry7%
C07CAcyclic or carbocyclic compounds7%
C07DHeterocyclic compounds7%
C07KPeptides7%
PatentTitleYear
11,760,977Compositions and methods for organoid generation and disease modeling202311,685,901Compositions and methods for organoid generation and disease modeling202311,542,309Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose202311,440,889Analogs of fexaramine and methods of making and using202211,376,264Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to SALK INST FOR BIOLOGICAL STUDI (5)· patent assignee history
2022Patents assigned to SALK INST BIOLOGICAL STUDIES (1)· patent assignee history
2022Patents assigned to UNIV SYDNEY (1)· patent assignee history
2022–2023Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SALK INST FOR BIOLOGICAL STUDI | 5 | 2022–2023 |
| SALK INST BIOLOGICAL STUDIES | 1 | 2022 |
| UNIV SYDNEY | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2023 |